Teladoc Health, Inc. (0LDR.L)
USD 7.3
(3.11%)
USD 7.3
(3.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -248.55 Million USD | -101.88% |
| 2022 | 13.19 Billion USD | 5622.65% |
| 2021 | -238.98 Million USD | 42.85% |
| 2020 | -418.18 Million USD | -466.48% |
| 2019 | -73.82 Million USD | -4.19% |
| 2018 | -70.85 Million USD | 6.02% |
| 2017 | -75.39 Million USD | -20.31% |
| 2016 | -62.66 Million USD | -12.33% |
| 2015 | -55.78 Million USD | -268.22% |
| 2014 | -15.15 Million USD | -158.14% |
| 2013 | -5.86 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -49.19 Million USD | 36.18% |
| 2024 Q3 | -44.4 Million USD | 9.74% |
| 2024 Q1 | -77.07 Million USD | 11.54% |
| 2023 Q1 | -49.01 Million USD | -101.31% |
| 2023 Q3 | -64.72 Million USD | -35.74% |
| 2023 Q2 | -47.68 Million USD | 2.71% |
| 2023 FY | -248.55 Million USD | -101.88% |
| 2023 Q4 | -87.13 Million USD | -34.62% |
| 2022 Q3 | -70.13 Million USD | -10.17% |
| 2022 Q1 | -64.87 Million USD | -74.04% |
| 2022 FY | 13.19 Billion USD | 5622.65% |
| 2022 Q4 | 3.75 Billion USD | 5447.9% |
| 2022 Q2 | -63.66 Million USD | 1.87% |
| 2021 FY | -238.98 Million USD | 42.85% |
| 2021 Q2 | -78.94 Million USD | 6.77% |
| 2021 Q3 | -60.57 Million USD | 23.27% |
| 2021 Q4 | -37.27 Million USD | 38.47% |
| 2021 Q1 | -84.67 Million USD | 81.53% |
| 2020 FY | -418.18 Million USD | -466.48% |
| 2020 Q4 | -458.5 Million USD | -2224.49% |
| 2020 Q3 | -19.72 Million USD | -174.76% |
| 2020 Q2 | -7.17 Million USD | 65.83% |
| 2020 Q1 | -21.01 Million USD | -34.79% |
| 2019 Q4 | -15.58 Million USD | 21.84% |
| 2019 Q2 | -22.02 Million USD | 3.78% |
| 2019 FY | -73.82 Million USD | -4.19% |
| 2019 Q1 | -22.88 Million USD | -28.31% |
| 2019 Q3 | -19.94 Million USD | 9.44% |
| 2018 Q4 | -17.83 Million USD | -13.05% |
| 2018 Q2 | -18.14 Million USD | 4.95% |
| 2018 Q3 | -15.77 Million USD | 13.05% |
| 2018 FY | -70.85 Million USD | 6.02% |
| 2018 Q1 | -19.09 Million USD | 22.26% |
| 2017 Q3 | -21.54 Million USD | -48.64% |
| 2017 Q1 | -14.8 Million USD | -11.88% |
| 2017 FY | -75.39 Million USD | -20.31% |
| 2017 Q2 | -14.49 Million USD | 2.09% |
| 2017 Q4 | -24.55 Million USD | -14.01% |
| 2016 Q1 | -14.71 Million USD | -2.57% |
| 2016 FY | -62.66 Million USD | -12.33% |
| 2016 Q4 | -13.23 Million USD | 34.69% |
| 2016 Q3 | -20.25 Million USD | -40.07% |
| 2016 Q2 | -14.46 Million USD | 1.72% |
| 2015 Q4 | -14.34 Million USD | -13.9% |
| 2015 Q2 | -16.25 Million USD | -29.05% |
| 2015 Q1 | -12.59 Million USD | -101.58% |
| 2015 Q3 | -12.59 Million USD | 22.5% |
| 2015 FY | -55.78 Million USD | -268.22% |
| 2014 Q2 | -2.85 Million USD | -30.62% |
| 2014 Q4 | -6.24 Million USD | -61.97% |
| 2014 Q1 | -2.18 Million USD | 0.0% |
| 2014 FY | -15.15 Million USD | -158.14% |
| 2014 Q3 | -3.85 Million USD | -34.95% |
| 2013 FY | -5.86 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | -88.622% |
| Accuray Incorporated | 504 Thousand USD | 49416.071% |
| Align Technology, Inc. | 643.33 Million USD | 138.635% |
| Elevance Health Inc. | 133.96 Billion USD | 100.186% |
| AxoGen, Inc. | -21.46 Million USD | -1058.107% |
| Boston Scientific Corporation | 2.34 Billion USD | 110.608% |
| CVS Health Corporation | 13.74 Billion USD | 101.809% |
| Cardinal Health, Inc. | 1.24 Billion USD | 119.996% |
| Centene Corporation | 2.93 Billion USD | 108.483% |
| DaVita Inc. | 1.6 Billion USD | 115.508% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 102.582% |
| Hologic, Inc. | 970.2 Million USD | 125.619% |
| Humana Inc. | 4.01 Billion USD | 106.194% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 122.655% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 134.255% |
| Masimo Corporation | 136.5 Million USD | 282.09% |
| McKesson Corporation | 3.9 Billion USD | 106.358% |
| Patterson Companies, Inc. | 252.92 Million USD | 198.272% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 119.695% |
| ResMed Inc. | 1.31 Billion USD | 118.831% |
| Henry Schein, Inc. | 615 Million USD | 140.415% |
| Universal Health Services, Inc. | 1.17 Billion USD | 121.147% |
| Veeva Systems Inc. | 429.33 Million USD | 157.893% |
| Baxter International Inc. | 390 Million USD | 163.732% |
| Becton, Dickinson and Company | 2.11 Billion USD | 111.774% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 114.068% |
| Danaher Corporation | 5.38 Billion USD | 104.619% |
| Stryker Corporation | 3.88 Billion USD | 106.393% |
| Medtronic plc | 5.14 Billion USD | 104.832% |